Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility. 2014

Christopher B Brooke, and William L Ince, and Jiajie Wei, and Jack R Bennink, and Jonathan W Yewdell
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

The influenza A virus (IAV) genome is divided into eight distinct RNA segments believed to be copackaged into virions with nearly perfect efficiency. Here, we describe a mutation in IAV nucleoprotein (NP) that enhances replication and transmission in guinea pigs while selectively reducing neuraminidase (NA) gene segment packaging into virions. We show that incomplete IAV particles lacking gene segments contribute to the propagation of the viral population through multiplicity reactivation under conditions of widespread coinfection, which we demonstrate commonly occurs in the upper respiratory tract of guinea pigs. NP also dramatically altered the functional balance of the viral glycoproteins on particles by selectively decreasing NA expression. Our findings reveal novel functions for NP in selective control of IAV gene packaging and balancing glycoprotein expression and suggest a role for incomplete gene packaging during host adaptation and transmission.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009698 Nucleoproteins Proteins conjugated with nucleic acids. Nucleoprotein
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D019065 Virus Assembly The assembly of VIRAL STRUCTURAL PROTEINS and nucleic acid (VIRAL DNA or VIRAL RNA) to form a VIRUS PARTICLE. Viral Assembly,Assembly, Viral,Assembly, Virus

Related Publications

Christopher B Brooke, and William L Ince, and Jiajie Wei, and Jack R Bennink, and Jonathan W Yewdell
September 2016, Nature communications,
Christopher B Brooke, and William L Ince, and Jiajie Wei, and Jack R Bennink, and Jonathan W Yewdell
May 2022, Journal of virology,
Christopher B Brooke, and William L Ince, and Jiajie Wei, and Jack R Bennink, and Jonathan W Yewdell
October 2005, Antimicrobial agents and chemotherapy,
Christopher B Brooke, and William L Ince, and Jiajie Wei, and Jack R Bennink, and Jonathan W Yewdell
May 2008, Journal of virology,
Christopher B Brooke, and William L Ince, and Jiajie Wei, and Jack R Bennink, and Jonathan W Yewdell
October 1968, Biochimica et biophysica acta,
Christopher B Brooke, and William L Ince, and Jiajie Wei, and Jack R Bennink, and Jonathan W Yewdell
July 2020, Journal of virology,
Christopher B Brooke, and William L Ince, and Jiajie Wei, and Jack R Bennink, and Jonathan W Yewdell
March 2024, Journal of virology,
Christopher B Brooke, and William L Ince, and Jiajie Wei, and Jack R Bennink, and Jonathan W Yewdell
March 1985, FEBS letters,
Christopher B Brooke, and William L Ince, and Jiajie Wei, and Jack R Bennink, and Jonathan W Yewdell
January 2021, Frontiers in microbiology,
Christopher B Brooke, and William L Ince, and Jiajie Wei, and Jack R Bennink, and Jonathan W Yewdell
April 1990, Journal of virology,
Copied contents to your clipboard!